Literature DB >> 2227250

Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan.

J Hayashi1, A Noguchi, K Nakashima, M Morofuji, S Kashiwagi.   

Abstract

A large number of chronic hepatitis B surface antigen (HBsAg) carriers in Okinawa, Japan were tested for antibody to HBsAg (anti-HBs), by both radioimmunoassay and enzyme immunoassay methods. Concurrence of HBsAg and anti-HBs was found in 166 (26.1%). We found no clear predominance of either liver damage or hepatitis B e antigen (HBeAg) in the concurrent carriers studied. Antibody to pre-S2 antigen (anti-pre-S2) was detected in 16 (9.6%) of 166 subjects with concurrent markers, 15 of these 16 carriers were positive for antibody to HBeAg (anti-HBe). Anti-pre-S2 was correlated with anti-HBe rather than with anti-HBs. The distribution of HBsAg subtypes among carriers determined to have subtypes was 76.7% adw, 22.0% adr, 0.2% ayr, 0.9% adwr, and 0.2% adyr. The distribution of anti-HBs subtypes among concurrent carriers was 51.5% anti-r, 21.4% anti-w, 15.5% anti-d, and 10.7% anti-y. Concurrent carriers had HBsAg of one subtype and heterotypic anti-HBs. Because the HBsAg subtype ay is rare in this area, it is hard to believe that the concurrent carriers with anti-y were infected with hepatitis B virus of which the HBsAg subtype was ay. A dual infection was highly unlikely. It seems that some of the concurrent carriers correlate with compound subtypes adwr and adyr.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227250     DOI: 10.1007/bf02779359

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  21 in total

1.  Incidence of HBsAg, anti-HBs and subtypes ad and ay in a general hospital: correlation with clinical data and its significance as a public health problem.

Authors:  M Telischi; F Steigmann; N Canlas; R Foemmel; R Decker; C Ling
Journal:  Am J Gastroenterol       Date:  1977-05       Impact factor: 10.864

2.  The loss of subtypic determinants in alleles, d/y or w/r, on hepatitis B surface antigen.

Authors:  H Okamoto; S Omi; Y Wang; Y Itoh; F Tsuda; T Tanaka; Y Akahane; Y Miyakawa; M Mayumi
Journal:  Mol Immunol       Date:  1989-02       Impact factor: 4.407

3.  HBs antigen subtypes among acute hepatitis patients in Japan: evidence of imported hepatitis.

Authors:  S Shiina; H Fujino; H Yasuda; T Kawabe; K Tagawa; T Unuma; M Yoneyama; T Ohmori; S Suzuki
Journal:  Am J Gastroenterol       Date:  1988-07       Impact factor: 10.864

4.  Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers.

Authors:  B Stimmel; S Vernace; F Schaffner
Journal:  JAMA       Date:  1975-12-15       Impact factor: 56.272

5.  A family infected with hepatitis B and with concurrently circulating HBsAg and heterotypic anti-HBs.

Authors:  J C Thijs; L van Bergeijk; R A Heijtink; A C Douwes; S G Meuwissen
Journal:  Hepatogastroenterology       Date:  1984-04

6.  Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr.

Authors:  H Okamoto; M Imai; F Tsuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

7.  Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.

Authors:  C G Trepo; D Robert; J Motin; D Trepo; M Sepetjian; A M Prince
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

8.  Hepatitis B virus transmission in nursery schools.

Authors:  J Hayashi; S Kashiwagi; H Nomura; W Kajiyama; H Ikematsu
Journal:  Am J Epidemiol       Date:  1987-03       Impact factor: 4.897

9.  An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan.

Authors:  S Kashiwagi; J Hayashi; H Ikematsu; H Nomura; T Kusaba; T Shingu; K Hayashida; M Kaji
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

10.  Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum.

Authors:  E Tabor; R J Gerety; L A Smallwood; L F Barker
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

View more
  6 in total

Review 1.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

2.  Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B.

Authors:  Jian Wang; Weimao Ding; Jiacheng Liu; Yong Liu; Xiaomin Yan; Juan Xia; Weihua Wu; Bei Jia; Yuxin Chen; Dongmei Gao; Shuqin Hong; Xiaohong Wang; Li Wang; Xin Tong; Shengxia Yin; Zhaoping Zhang; Jie Li; Rui Huang; Chao Wu
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  Prevalence and presentation of hepatitis B and C virus (HBV and HCV) infection in Vietnamese Americans via serial community serologic testing.

Authors:  Kelvin Nguyen; Thai Van Nguyen; Duke Shen; Victor Xia; Diep Tran; Khanh Banh; Victor Ruan; Ke-Qin Hu
Journal:  J Immigr Minor Health       Date:  2015-02

4.  Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B.

Authors:  Min-Sun Kwak; Goh-Eun Chung; Jong In Yang; Jeong Yoon Yim
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

Review 5.  Paradoxical HBsAg and anti-HBs coexistence among Chronic HBV Infections: Causes and Consequences.

Authors:  Xinyi Jiang; Le Chang; Ying Yan; Lunan Wang
Journal:  Int J Biol Sci       Date:  2021-03-11       Impact factor: 6.580

6.  Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis.

Authors:  Yu-Lan Chen; Ying-Qian Mo; Dong-Hui Zheng; Jian-Da Ma; Jun Jing; Lie Dai
Journal:  Med Sci Monit       Date:  2017-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.